Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis
Open Access
- 8 December 2022
- journal article
- research article
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-19
Abstract
Background. Fatty acid binding protein 4 (FABP4) is mainly involved in the regulation of systemic metabolism through various lipid signaling pathways. Metabolic reprogramming is one of the important factors in the development and progression of cancer. It has been recently reported that FABP4 is closely related to the development of cancer and may be involved in tumor invasion and metastasis. Methods. In this study, we explored the expression pattern of FABP4 in pancancer through TCGA and CPTAC. Using TCGA, Kaplan-Meier Plotter, and STRING databases, to explore its diagnostic and prognostic value, and function through GO/KEGG and GSEA. Then, using the TIMER2.0 database, we investigated the correlation between FABP4 expression and immune infiltration in cancers, especially stomach adenocarcinomas (STAD) and colorectal adenocarcinoma (COADREAD). Results. Compared with normal tissues, the expression of FABP4 in more than 10 tumor tissues was lower ( ). Through the receiver operating characteristic (ROC) curve, the diagnostic value was found higher in colorectal cancer, breast cancer, thyroid cancer, and lung cancer, with the area under the curve . Through the K-M curve, FABP4 was found to correlate to the prognosis of various cancers. The results of gastric cancer and colorectal cancer are consistent. The low-expression group has a better prognosis than the high-expression group, and the expression of FABP4 in the early T and N stages of gastrointestinal tumors is lower. FABP4 highly expressed gene set is mostly enriched in extracellular matrix degradation and cell adhesion functions. Gastrointestinal tumors with high expression of FABP4 may have more immunosuppressive effects on macrophages and have a worse prognosis. Conclusion. FABP4 can be used as a diagnostic and prognostic biomarker in pancancer, and its high expression in gastrointestinal tumors suggests poor prognosis. This may be correlated to the immune infiltration of macrophages and epithelial-mesenchymal transition.Keywords
Funding Information
- Suzhou Clinical Medical Expert Team (SZYJTD201824, SYK201817)
- Institute-Level Scientific Research Project of Jiangsu Shengze Hospital (SZYJTD201824, SYK201817)
This publication has 48 references indexed in Scilit:
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progressionInternational Journal of Cancer, 2014
- Expression of fatty acid binding protein 4 is involved in the cell growth of oral squamous cell carcinomaOncology Reports, 2014
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity, 2013
- Fatty Acid-Binding Protein 4 and Incident Heart Failure: the Cardiovascular Health StudyEuropean Journal of Heart Failure, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: A multicentric 2004 national PHRC studyInternational Journal of Oncology, 2012
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growthNature Medicine, 2011
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- The MAPK signalling pathways and colorectal cancerThe Lancet Oncology, 2005